{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:33:34Z","timestamp":1779114814578,"version":"3.51.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Aims:<\/jats:bold> The aim of the study is to investigate the association between the degree of ischemia due to coronary microvascular dysfunction (CMD) and the left ventricular (LV) tissue characteristics, systolic performance, and clinical manifestations in hypertrophic cardiomyopathy (HCM).<\/jats:p><jats:p><jats:bold>Methods and Results:<\/jats:bold> This prospective study enrolled 75 patients with HCM without obstructive epicardial coronary artery disease. Each patient underwent cardiovascular magnetic resonance (CMR) including parametric mapping, perfusion imaging during regadenoson-induced hyperemia, late gadolinium enhancement (LGE) and three-dimensional longitudinal, circumferential, and radial strains analysis. Electrocardiogram, 24-h Holter recording, and cardiopulmonary exercise testing (CPET) were performed to assess arrhythmias and functional capacity. In total, 47 (63%) patients were men with the mean age of 54.6 (14.8) years, 51 (68%) patients had non-obstructive HCM, maximum wall thickness (MWT) was 20.2 (4.6) mm, LV ejection fraction (LVEF) was 71.6 (8.3%), and ischemic burden was 22.5 (16.9%) of LV. Greater MWT was associated with the severity of ischemia (\u03b2-estimate:1.353, 95% CI:0.182; 2.523, <jats:italic>p<\/jats:italic> = 0.024). Ischemic burden was strongly associated with higher values of native T1 (\u03b2-estimate:9.018, 95% CI:4.721; 13.315, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). The association between ischemia and LGE was significant in following subgroup analyses: MWT 15\u201320 mm (\u03b2-estimate:1.941, 95% CI:0.738; 3.143, <jats:italic>p<\/jats:italic> = 0.002), non-obstructive HCM (\u03b2-estimate:1.471, 95% CI:0.258; 2.683, <jats:italic>p<\/jats:italic> = 0.019), women (\u03b2-estimate:1.957, 95% CI:0.423; 3.492, <jats:italic>p<\/jats:italic> = 0.015) and age &amp;lt;40 years (\u03b2-estimate:4.874, 95% CI:1.155; 8.594, <jats:italic>p<\/jats:italic> = 0.016). Ischemia in \u226521% of LV was associated with LGE &amp;gt;15% (AUC 0.766, sensitivity 0.724, specificity 0.659). Ischemia was also associated with atrial fibrillation or flutter (AF\/AFL) (OR-estimate:1.481, 95% CI:1.020; 2.152, <jats:italic>p<\/jats:italic> = 0.039), but no association was seen for non-sustained ventricular tachycardia. Ischemia was associated with shorter time to anaerobic threshold (\u03b2-estimate: \u22120.442, 95% CI: \u22120.860; \u22120.023, <jats:italic>p<\/jats:italic> = 0.039).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In HCM, ischemia associates with morphological markers of severity of disease, fibrosis, arrhythmia, and functional capacity.<\/jats:p>","DOI":"10.3389\/fcvm.2021.761860","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T05:49:34Z","timestamp":1639720174000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy"],"prefix":"10.3389","volume":"8","author":[{"given":"S\u00edlvia","family":"Aguiar Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boban","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Fiarresga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Lu\u00edsa","family":"Papoila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gon\u00e7alo","family":"Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Baquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Cruz","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Mota Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds Rocha","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Zamorano","year":"2014","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e003090","DOI":"10.1161\/CIRCHEARTFAILURE.116.003090","article-title":"Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy","volume":"9","author":"Galati","year":"2016","journal-title":"Circ Heart Fail"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson."},{"key":"B7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1161\/CIRCIMAGING.112.000192","article-title":"Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume","volume":"6","author":"Miller","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagin","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson."},{"key":"B9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/heart.84.5.476","article-title":"Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis and small vessel disease","volume":"84","author":"Varnava","year":"2000","journal-title":"Heart."},{"key":"B10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1056\/NEJMoa1716734","article-title":"Magnetic resonance perfusion or fractional flow reserve in coronary disease","volume":"380","author":"Nagel","year":"2019","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1148\/radiol.10090526","article-title":"Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging","volume":"258","author":"Harrigan","year":"2011","journal-title":"Radiology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson."},{"key":"B15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2019.03.060","article-title":"Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy","volume":"291","author":"Fo\u00e0","year":"2019","journal-title":"Int J Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0735-1097(00)00594-5","article-title":"Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy","volume":"35","author":"Hamasaki","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrcardio.2011.159","article-title":"Mechanisms of disease: hypertrophic cardiomyopathy","volume":"9","author":"Frey","year":"2012","journal-title":"Nat Rev Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","article-title":"Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations","volume":"58","author":"Olivotto","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jacc.2009.04.026","article-title":"Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy. correlation with histopathology and prevalence of ventricular tachycardia","volume":"54","author":"Kwon","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jcmg.2020.09.037","article-title":"Progression of myocardial fibrosis in hypertrophic cardiomyopathy: a cardiac magnetic resonance study","volume":"14","author":"Habib","year":"2021","journal-title":"JACC Cardiovasc Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.119.040271","article-title":"Hypertrophic cardiomyopathy-related sudden cardiac death in young people in Ontario","volume":"140","author":"Weissler-Snir","year":"2019","journal-title":"Circulation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation."},{"key":"B25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.accreview.2005.10.042","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"14","author":"Olivotto","year":"2005","journal-title":"ACC Curr J Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jacc.2009.04.072","article-title":"The case for myocardial ischemia in hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0735-1097(99)00492-1","article-title":"Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death","volume":"35","author":"Shirani","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/europace\/euaa348","article-title":"Arrhythmogenic potential ofmyocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death","volume":"2","author":"Finocchiaro","year":"2020","journal-title":"Europace."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12968-016-0223-8","article-title":"Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement","volume":"18","author":"Villa","year":"2016","journal-title":"J Cardiovasc Magn Reson."},{"key":"B30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/heartjnl-2019-315848","article-title":"Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy","volume":"106","author":"Camaioni","year":"2019","journal-title":"Heart"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2967\/jnumed.107.050138","article-title":"Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy","volume":"49","author":"Sotgia","year":"2008","journal-title":"J Nucl Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e111366","DOI":"10.1371\/journal.pone.0111366","article-title":"Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: a marker of advanced disease and electrical myocardial instability","volume":"9","author":"Todiere","year":"2014","journal-title":"PLoS ONE"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/heartjnl-2019-315818","article-title":"Exercise and myocardial injury in hypertrophic cardiomyopathy","volume":"106","author":"Cramer","year":"2020","journal-title":"Heart."},{"key":"B34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12350-008-9005-5","article-title":"Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy","volume":"16","author":"Sciagr\u00e0","year":"2009","journal-title":"J Nucl Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.002248","article-title":"Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy","volume":"8","author":"Coats","year":"2015","journal-title":"Circ Hear Fail."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.amjcard.2012.01.363","article-title":"Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"109","author":"Sorajja","year":"2012","journal-title":"Am J Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1253\/circj.CJ-16-0432","article-title":"Heart failure progression in hypertrophic cardiomyopathy - Possible insights from cardiopulmonary exercise testing","volume":"80","author":"Magr\u00ec","year":"2016","journal-title":"Circ J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jchf.2014.11.011","article-title":"Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy. A potential role for comprehensive noninvasive hemodynamic assessment","volume":"3","author":"Finocchiaro","year":"2015","journal-title":"JACC Hear Fail."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.761860\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T05:49:36Z","timestamp":1639720176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.761860\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":38,"alternative-id":["10.3389\/fcvm.2021.761860"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.761860","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"article-number":"761860"}}